1. Home
  2. PROV vs EQ Comparison

PROV vs EQ Comparison

Compare PROV & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

N/A

Current Price

$18.13

Market Cap

107.4M

Sector

Finance

ML Signal

N/A

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$1.50

Market Cap

89.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PROV
EQ
Founded
1956
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.4M
89.4M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
PROV
EQ
Price
$18.13
$1.50
Analyst Decision
Hold
Strong Buy
Analyst Count
2
9
Target Price
★ $18.50
$8.56
AVG Volume (30 Days)
12.9K
★ 379.1K
Earning Date
10-27-2026
11-20-2026
Dividend Yield
★ 3.08%
N/A
EPS Growth
★ 10.75
N/A
EPS
★ 1.03
N/A
Revenue
N/A
★ $41,095,000.00
Revenue This Year
$4.36
N/A
Revenue Next Year
$0.72
N/A
P/E Ratio
$17.67
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.95
$1.16
52 Week High
$18.99
$6.20

Technical Indicators

Market Signals
Indicator
PROV
EQ
Relative Strength Index (RSI) 41.30 50.62
Support Level $18.04 $1.30
Resistance Level $18.91 $1.51
Average True Range (ATR) 0.16 0.13
MACD 0.00 0.03
Stochastic Oscillator 10.10 82.86

Price Performance

Historical Comparison
PROV
EQ

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: